Join Us for a Discussion on Neuroethics for Novel Neurotechnologies
- Details
Progress in advancing neurotechnologies is occurring at a time of change in health and social landscapes. As novel brain technologies traverse the realm of preclinical experimentation to real world treatments, questions of readiness, equitable patient access, legal, and intellectual rights surface.
Join us Monday, April 19, at 3:00 pm Eastern to hear leaders of the Pan-Canadian Neurotechnology Ethics Collaboration; Plenary Speaker, Helen Mayberg, MD; and representatives from the Foundation engage in what promises to be an insightful discussion.
WEBINAR
Neuroethics for Novel Neurotechnologies
Monday, April 19, 2021
3:00 PM Eastern
Meet the Panelists
Helen Mayberg, MD
Ichan School of Medicine at Mount Sinai
Judy Illes, PhD
University of British Columbia
Nir Lipsman, MD, PhD
Sunnybrook Health Sciences Institute
Patrick McDonald, MD
BC Children's Hospital Research Institute
Matthew Burke, MD
Sunnybrook Research Institute
Jennifer Chandler, LLB, LLM
Centre for Law, Technology and Society
Jessica Foley, PhD
Focused Ultrasound Foundation
Suzanne LeBlang, MD
Focused Ultrasound Foundation
Focused Ultrasound–Enhanced Blood Test for Brain Tumors: World-First Results Published
- Details
Key Points
- Liquid biopsy is a blood test used to diagnose and monitor treatment of brain tumors.
- Nine patients with glioblastoma (GBM) underwent liquid biopsy before and after focused ultrasound treatment that disrupted the blood-brain barrier to enhance chemotherapy delivery.
- This first-in-human study – recently published in Neuro-Oncology – found focused ultrasound enriched the amount of circulating brain tumor biomarkers in the peripheral blood.
- The results suggest that focused ultrasound could reduce the need for invasive brain tumor biopsies and allow better monitoring of GBM treatment responses.
Focused Ultrasound for Opioid Use Disorder: First Patient Treated in New Trial
- Details
Key Points
- Researchers at West Virginia University have treated the first patient in a first-in-the-world clinical trial investigating focused ultrasound to address opioid use disorder.
- The trial aims to reduce patients’ substance cravings and addictive behaviors.
- The COVID-19 pandemic has intensified the addiction crisis, and researchers hope to be able to offer patients a new treatment option.